ANI Pharmaceuticals, Inc. (ANIP) vs uniQure N.V. (QURE)
A side-by-side comparison of ANI Pharmaceuticals, Inc. and uniQure N.V. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ANIP
ANI Pharmaceuticals, Inc.
$71.52HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
QURE
uniQure N.V.
$23.06HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ANIP vs QURE
growth of $100 · dividends reinvested · last 10yANIP +5.2% (+0.5%/yr)QURE +188.2% (+11.2%/yr)QURE compounded faster over this window
ANIP QURE
ANIP vs QURE: by the numbers
- •ANIP is the larger company ($1.63B vs $1.60B market cap).
- •ANIP is profitable (10.82% net margin) while QURE runs a net loss (-1350.73%).
- •ANIP grew revenue faster over the past five years (35.61% vs -48.20% CAGR).
Metrics side by side
Valuation
| Metric | ANIP | QURE |
|---|---|---|
| P/E ratio | 15.45 | N/A |
| Forward P/E | 7.71 | N/A |
| P/S ratio | 1.66 | 85.67 |
| P/B ratio | 2.72 | 4.94 |
| EV / EBITDA | 6.76 | N/A |
Profitability
| Metric | ANIP | QURE |
|---|---|---|
| Gross margin | 51.01% | 89.53% |
| Operating margin | 15.35% | -1166.77% |
| Net margin | 10.82% | -1350.73% |
| ROE | 17.72% | -77.83% |
| ROIC | 9.26% | -22.55% |
Growth (annualized)
| Metric | ANIP | QURE |
|---|---|---|
| Revenue CAGR (5Y) | 35.61% | -48.20% |
| Total return CAGR (5Y) | 16.86% | -6.16% |
Frequently asked
- Which has grown faster, ANIP or QURE?
- Over the past five years, ANIP grew revenue faster — ANIP at a 35.61% CAGR versus QURE at -48.20%.
- Is ANIP or QURE more profitable?
- ANIP runs the higher net margin — ANIP at 10.82% versus QURE at -1350.73%.
- How have ANIP and QURE total returns compared?
- Over the past 10 years, ANIP delivered 0.51% and QURE delivered 11.17% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
ANI Pharmaceuticals P/E ratioANI Pharmaceuticals ROEuniQure ROEANI Pharmaceuticals operating marginuniQure operating marginANI Pharmaceuticals revenue growthuniQure revenue growthANI Pharmaceuticals free cash flowuniQure free cash flow
ANI Pharmaceuticals & uniQure appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.